TY - JOUR
T1 - STABILITY ANALYSIS of A MATHEMATICAL MODEL for CHRONIC MYELOID LEUKEMIA ERADICATION
AU - Bunimovich-Mendrazitsky, Svetlana
AU - Shaikhet, Leonid
N1 - Publisher Copyright:
© 2021 World Scientific Publishing Company.
PY - 2021/3
Y1 - 2021/3
N2 - We analyze a mathematical model for the treatment of chronic myeloid leukemia (CML). The model is designed for complete recovery of CML patients after treatment. The model developed in the paper [Bunimovich-Mendrazitsky S, Kronik N, Vainstein V, Optimization of interferon-alpha and imatinib combination therapy for CML: A modeling approach, Adv Theory Simul 2(1):1800081, 2018] introduced a combined treatment of CML based on imatinib therapy and immunotherapy. Immunotherapy based on Interferon alpha-2a (IFN-α) affects stem and mature cancer cell mortality, and leads to outcome improvements in the combined therapy. The qualitative character of our results shows that additional therapy for the complete cure of CML patients is required. This additional treatment is tumor infiltrating lymphocytes (TIL) along with a combination imatinib and IFN-α treatment. The model examines the interaction between CML cancer cells and effector cells, using an ODE system. Stability analysis of the model defines conditions when imatinib treatment might lead to the eradication of CML with IFN-α and TIL. Three equilibria are investigated for the proposed model. Stability conditions for equilibria are formulated in terms of the linear matrix inequalities (LMIs).
AB - We analyze a mathematical model for the treatment of chronic myeloid leukemia (CML). The model is designed for complete recovery of CML patients after treatment. The model developed in the paper [Bunimovich-Mendrazitsky S, Kronik N, Vainstein V, Optimization of interferon-alpha and imatinib combination therapy for CML: A modeling approach, Adv Theory Simul 2(1):1800081, 2018] introduced a combined treatment of CML based on imatinib therapy and immunotherapy. Immunotherapy based on Interferon alpha-2a (IFN-α) affects stem and mature cancer cell mortality, and leads to outcome improvements in the combined therapy. The qualitative character of our results shows that additional therapy for the complete cure of CML patients is required. This additional treatment is tumor infiltrating lymphocytes (TIL) along with a combination imatinib and IFN-α treatment. The model examines the interaction between CML cancer cells and effector cells, using an ODE system. Stability analysis of the model defines conditions when imatinib treatment might lead to the eradication of CML with IFN-α and TIL. Three equilibria are investigated for the proposed model. Stability conditions for equilibria are formulated in terms of the linear matrix inequalities (LMIs).
KW - Interferon and Tumor Infiltrating Lymphocytes
KW - Linear Matrix Inequalities (LMIs)
KW - Stability Theory
KW - Stem and Mature Leukemic Cells
KW - T-Cell Response
UR - http://www.scopus.com/inward/record.url?scp=85103497950&partnerID=8YFLogxK
U2 - 10.1142/S0218339021500078
DO - 10.1142/S0218339021500078
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85103497950
SN - 0218-3390
VL - 29
SP - 169
EP - 191
JO - Journal of Biological Systems
JF - Journal of Biological Systems
IS - 1
ER -